Answers are grounded in this paper and cite their sources.
Characterization of cardiovascular progenitor fate shows Zbtb16 deletion directs them toward endothelial and fibroblast lineages, highlighting the role of IGF2BP3.
Cardiovascular progenitors (CPs) are responsible for generating diverse cardiac cell populations, exhibiting significant transcriptional heterogeneity. However, the mechanisms regulating fate plasticity among heterogeneous CP subpopulations remain poorly understood. Here, we characterize three CP subpopulations derived from pluripotent stem cells and find that deletion of the ZBTB family protein Zbtb16 disrupts the branching trajectory of Early-CPs, redirecting them toward CPs committed to endothelial cells and cardiac fibroblasts (EC/CF-CPs) rather than to cardiomyocytes (CM-CPs), which potentially leads to ventricular non-compaction and impaired cardiac function in mice. Mechanistically, Zbtb16 interacts with the N6-methyladenosine (m6A) reader IGF2BP3 to post-transcriptionally recognize and stabilize mRNAs of key genes critical for CM-CP subpopulation determination. Collectively, our findings establish Zbtb16 as a key regulator of fate plasticity in heterogeneous CP subpopulations and reveal its interplay with IGF2BP3 to impact m6A-modified mRNA stabilization, providing insights into the intrinsic connections between CP subpopulation plasticity and cardiovascular multi-lineage fate determination.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: